PUSH BACK AGAINST YOUR SCHIZOPHRENIA Trademark

Trademark Overview

On Monday, September 14, 2020, a trademark application was filed for PUSH BACK AGAINST YOUR SCHIZOPHRENIA with the United States Patent and Trademark Office. The USPTO has given the PUSH BACK AGAINST YOUR SCHIZOPHRENIA trademark a serial number of 90178739. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, June 18, 2024. This trademark is owned by Alkermes Pharma Ireland Limited. The PUSH BACK AGAINST YOUR SCHIZOPHRENIA trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, providing awareness programs in the nature of educational support presentations for patients and caregivers in the field of navigating pharmaceutical treatments for and managing people living with psychiatric diseases and conditions in the nature of schizophrenia, depression, major depressive disorder, anxiety, treatment resistant depression, bipolar depression, bipolar disorder, and metabolic diseases in the nature of dyslipidemia; none of the foregoing for use in the treatment or management of neurological diseases and none of the foregoing for use with fitness or exercise programs
push back against your schizophrenia

General Information

Serial Number90178739
Word MarkPUSH BACK AGAINST YOUR SCHIZOPHRENIA
Filing DateMonday, September 14, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2022

Trademark Statements

Goods and ServicesEducational services, namely, providing awareness programs in the nature of educational support presentations for patients and caregivers in the field of navigating pharmaceutical treatments for and managing people living with psychiatric diseases and conditions in the nature of schizophrenia, depression, major depressive disorder, anxiety, treatment resistant depression, bipolar depression, bipolar disorder, and metabolic diseases in the nature of dyslipidemia; none of the foregoing for use in the treatment or management of neurological diseases and none of the foregoing for use with fitness or exercise programs
NOT AVAILABLE"SCHIZOPHRENIA"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateWednesday, March 24, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 4
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Trademark Events

Event DateEvent Description
Thursday, September 17, 2020NEW APPLICATION ENTERED
Tuesday, October 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 8, 2021NON-FINAL ACTION WRITTEN
Monday, February 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 26, 2021ASSIGNED TO EXAMINER
Monday, February 8, 2021NON-FINAL ACTION E-MAILED
Wednesday, March 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 14, 2021NON-FINAL ACTION WRITTEN
Friday, May 14, 2021NON-FINAL ACTION E-MAILED
Friday, May 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 15, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 18, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, December 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 2, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 2, 2022SOU EXTENSION 1 GRANTED
Friday, September 2, 2022SOU EXTENSION 1 FILED
Monday, August 14, 2023SOU EXTENSION 3 FILED
Monday, August 14, 2023SOU EXTENSION 3 GRANTED
Wednesday, February 21, 2024SOU EXTENSION 4 GRANTED
Wednesday, February 21, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 21, 2024SOU EXTENSION 4 FILED
Thursday, February 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2024SOU EXTENSION 5 GRANTED
Tuesday, June 18, 2024SOU EXTENSION 5 FILED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 21, 2023SOU EXTENSION 2 FILED
Tuesday, February 21, 2023SOU EXTENSION 2 GRANTED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED

Related Keywords

schizophrenia your against back push diseases nature depression none bipolar disorder foregoing treatment programs educational